Rhythm Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Rhythm Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 228% to $77,428,000. Profit margin reached -239%. Total operating expenses were $252,483,000.
Profit Margin
| 2014 | 0 | -6.49M | |
|---|---|---|---|
| 2015 | 0 | -11.07M | |
| 2016 | 0 | -25.87M | |
| 2017 | 0 | -33.70M | |
| 2018 | 0 | -74.06M | |
| 2019 | 0 | -134.62M | |
| 2020 | 0 | -130.72M | |
| 2021 | 3.15M | -68.00M | -2156.21% |
| 2022 | 23.63M | -183.08M | -774.52% |
| 2023 | 77.42M | -184.67M | -238.52% |
RYTM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 77.42M | 23.63M | 3.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 9.30M | 2.13M | 599K | 690K | 834K | 0 | 223K | 0 | 0 | 0 |
Gross profit | 68.12M | 21.50M | 2.55M | -690K | -834K | 0 | -223K | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 134.95M | 108.63M | 104.12M | 90.45M | 109.45M | 50.33M | 22.89M | 19.59M | 7.14M | 5.28M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 252.48M | 200.66M | 172.61M | 136.57M | 146M | 78.41M | 32.41M | 25.90M | 10.57M | 6.49M |
Operating income | -184.35M | -179.15M | -170.05M | -136.57M | -146M | -78.41M | -32.41M | -25.90M | -10.57M | -6.49M |
Other income (expenses), net | 243K | -1.96M | 100.44M | 2.57M | 5.27M | 4.35M | -1.29M | 33K | -500K | 0 |
Income before tax | -184.11M | -181.11M | -69.61M | -133.99M | -140.72M | -74.06M | -33.70M | -25.87M | -11.07M | -6.49M |
Income tax expense | 564K | 1.96M | -1.60M | -3.26M | -6.10M | 4.35M | 1.07M | 0 | 0 | 0 |
Net income | -184.67M | -183.08M | -68.00M | -130.72M | -134.62M | -74.06M | -33.70M | -25.87M | -11.07M | -6.49M |
Earnings per share | ||||||||||
Basic EPS | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 |
Diluted EPS | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |